UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers

Journal of clinical oncology, 2014-03, Vol.32 (8), p.833-840

2014

Link zum Volltext

Verfügbarkeit prüfen

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes

Radiology, 2017-11, Vol.285 (2), p.472

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1331-1337

2008

Link zum Volltext

Verfügbarkeit prüfen

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3275-3283

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk-Reducing Salpingo-Oophorectomy in Patients With Germline Mutations in BRCA1 or BRCA2

Journal of clinical oncology, 2007-07, Vol.25 (20), p.2921-2927

2007

Link zum Volltext

Verfügbarkeit prüfen

Genome-Wide Association Studies of Cancer

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4255-4267

2010

Link zum Volltext

Verfügbarkeit prüfen

Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers

Gynecologic oncology, 2017-06, Vol.145 (3), p.549-554

2017

Link zum Volltext

Verfügbarkeit prüfen

SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance

Gynecologic oncology, 2010-10, Vol.119 (1), p.7-17

2010

Link zum Volltext

Verfügbarkeit prüfen

Selection of Endometrial Carcinomas for DNA Mismatch Repair Protein Immunohistochemistry Using Patient Age and Tumor Morphology Enhances Detection of Mismatch Repair Abnormalities

The American journal of surgical pathology, 2009-06, Vol.33 (6), p.925-933

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC)

International journal of gynecological cancer, 2013-11, Vol.23 (9), p.1603-1611

2013

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2009-01, Vol.101 (2), p.80-87

2009

Link zum Volltext

Verfügbarkeit prüfen

Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

Clinical cancer research, 2002-12, Vol.8 (12), p.3776-3781

2002

Link zum Volltext

Verfügbarkeit prüfen

BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews

Clinical cancer research, 2004-05, Vol.10 (9), p.2918-2921

2004

Link zum Volltext

Verfügbarkeit prüfen

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

Modern pathology, 2012-04, Vol.25 (4), p.625-636

2012

Link zum Volltext

Verfügbarkeit prüfen

Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families

JNCI : Journal of the National Cancer Institute, 2005-09, Vol.97 (18), p.1382-1384

2005

Link zum Volltext

Verfügbarkeit prüfen

Is There a Role for Ovarian Cancer Screening in High-Risk Women?

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1384-1386

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2

Cancer epidemiology, biomarkers & prevention, 2006-11, Vol.15 (11), p.2311-2313

2006

Link zum Volltext

Verfügbarkeit prüfen

Reducing the Risk of Gynecologic Cancer in the Lynch Syndrome

The New England journal of medicine, 2006-01, Vol.354 (3), p.293-295

2006

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide Association Studies of Cancer Predisposition

Hematology/oncology clinics of North America, 2010-10, Vol.24 (5), p.973-996

2010

Link zum Volltext

Verfügbarkeit prüfen

Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System

Cancer epidemiology, biomarkers & prevention, 2022-09, Vol.31 (9), p.1823-1829

2022

Link zum Volltext

Verfügbarkeit prüfen

Screening and Prevention of Hereditary Gynecologic Cancers

Seminars in oncology, 2007-10, Vol.34 (5), p.406-410

2007

Link zum Volltext

Verfügbarkeit prüfen

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions

Gynecologic oncology, 2007-11, Vol.107 (2), p.159-162

2007

Link zum Volltext

Verfügbarkeit prüfen

Improved survival for BRCA2‐associated serous ovarian cancer compared with both BRCA‐negative and BRCA1‐associated serous ovarian cancer

Cancer, 2012-08, Vol.118 (15), p.3703-3709

2012

Link zum Volltext

Verfügbarkeit prüfen

Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency

Modern pathology, 2014-10, Vol.27 (10), p.1405-1411

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(104)
Buchkapitel
(2)

Sprache

Englisch
(106)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199

Risk-Reducing Salpingo-Oophorectomy in Patients With Germline Mutations in BRCA1 or BRCA2

Genome-Wide Association Studies of Cancer

Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers

SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance

Selection of Endometrial Carcinomas for DNA Mismatch Repair Protein Immunohistochemistry Using Patient Age and Tumor Morphology Enhances Detection of Mismatch Repair Abnormalities

Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC)

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families

Is There a Role for Ovarian Cancer Screening in High-Risk Women?

Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2

Reducing the Risk of Gynecologic Cancer in the Lynch Syndrome

Genome-wide Association Studies of Cancer Predisposition

Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System

Screening and Prevention of Hereditary Gynecologic Cancers

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions

Improved survival for BRCA2‐associated serous ovarian cancer compared with both BRCA‐negative and BRCA1‐associated serous ovarian cancer

Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency

Suchergebnisse filtern